ClinicalTrials.Veeva

Menu

Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic (COVID-PRONE)

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

Sars-CoV2

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

SARS-CoV-2 induced by COVID 19, involved the hospitalization of 101,932 patients in France, including 4,007 in intensive care (source: Santé Publique France). Alsace was one of the most affected regions on the metropolitan territory with a large number of patients hospitalized at the University Hospital of Strasbourg.

In view of the seriousness of the epidemic and the rapid arrival of new patients requiring mechanical ventilation, 3 new intensive care units have been created on the NHC site alone, making it possible to accommodate a maximum of 111 patients (compared to 52 during normal periods).

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Criteria for inclusion :

  • Major patient (≥18 years old)
  • Patient hospitalized in intensive care at the NHC, diagnosed COVID + and requiring a VD session of which at least one is performed by the dedicated team.
  • patient who has not expressed, after information, his or her opposition to the re-use of his or her data for the purposes of this research

Exclusion criteria :

  • Subject who expressed opposition to participating in the study
  • Subject under guardianship, curatorship or safeguarding of justice

Trial contacts and locations

1

Loading...

Central trial contact

Bob HEGER, MD; Saïd CHAYER, PhD, HDR

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems